✦ LIBER ✦

Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada

✍ Scribed by Daria J. O’Reilly; Feng Xie; Eleanor Pullenayegum; Hertzel C. Gerstein; Janet Greb; Gord K. Blackhouse; Jean-Eric Tarride; Jim Bowen; Ron A. Goeree

Publisher: Springer Netherlands
Year: 2011
Tongue: English
Weight: 155 KB
Volume: 20
Category: Article
ISSN: 0962-9343
DOI: 10.1007/s11136-010-9828-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Health-related quality of life in patien

✍ E Orvik; OE Johansen; L Gullestad; KI Birkeland 📂 Article 📅 2006 🏛 Maney Publishing 🌐 English ⚖ 611 KB

Association of HbA1clevels with vascular

Association of HbA1clevels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds

✍ S. Zoungas; J. Chalmers; T. Ninomiya; Q. Li; M. E. Cooper; S. Colagiuri; G. Fulc 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 364 KB

Long-term lifestyle intervention lowers

Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study)

✍ H. Sone; S. Tanaka; S. Iimuro; S. Tanaka; K. Oida; Y. Yamasaki; S. Oikawa; S. Is 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 188 KB

No negative effects of a multi-factorial

No negative effects of a multi-factorial, intensified treatment on self-reported health status, treatment satisfaction, and diabetes-related distress in screen-detected type 2 diabetes patients. The ADDITION-Netherlands study

✍ Maureen van den Donk; Kees J. Gorter; Guy E. Rutten 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 160 KB

The effect of different doses of vitamin

The effect of different doses of vitamin D3on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial

✍ M. D. Witham; F. J. Dove; M. Dryburgh; J. A. Sugden; A. D. Morris; A. D. Struthe 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 151 KB

Efficacy and safety of the PPARγ partial

Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy

✍ Kim Henriksen; Inger Byrjalsen; Per Qvist; Henning Beck-Nielsen; Gitte Hansen; B 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB 👁 1 views

## Abstract ## Background Treatment of patients with perioxisome proliferator‐activated receptor‐γ full agonists are associated with weight gain, heart failure, peripheral oedema, and bone loss. However, the safety of partial perioxisome proliferator‐activated receptor‐γ agonists has not been esta